source
- FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1The U.S. Food and Drug Administration announced on August 5, 2026 that it has approved Orzeyful (oveporexton) tablets for adults with narcolepsy type 1. Orzeyful is the first therapy cleared to tr…
- AstraZeneca and BMS deny merger talks, Reuters says no dealReuters reported that rumors of a merger between AstraZeneca and Bristol Myers Squibb have been dismissed. A senior source close to the matter told Reuters there is no deal and no discussions betw…